title: Beneficial effect of prostaglandin E1 on hepatic allograft rejection following orthotopic liver transplantation.
authors.affiliation: Victorian Liver Transplant Unit, Austin Hospital, Heidelberg, Australia.
authors.forename: S
authors.initials: S
authors.lastname: Tancharoen
authors.forename: R M
authors.initials: RM
authors.lastname: Jones
authors.forename: P W
authors.initials: PW
authors.lastname: Angus
authors.forename: K J
authors.initials: KJ
authors.lastname: Hardy
mesh_terms: D000208:Acute Disease; D000527:Alprostadil / Q000008:administration & dosage / Q000494:pharmacology*; D006084:Graft Rejection / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007262:Infusions, Intravenous; D016031:Liver Transplantation / Q000009:adverse effects* / Q000276:immunology; D008775:Methylprednisolone / Q000008:administration & dosage; D016853:Muromonab-CD3 / Q000008:administration & dosage
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D000527:Alprostadil; D008775:Methylprednisolone